1	Bruton	_	NN	_	_	4	NMOD	_	_
2	's	_	POS	_	_	1	SUFFIX	_	_
3	tyrosine	_	NN	_	_	4	NMOD	_	_
4	kinase	_	NN	_	_	5	VMOD	_	_
5	is	_	VBZ	_	_	0	ROOT	_	_
6	required	_	VBN	_	_	5	VC	_	_
7	for	_	IN	_	_	6	VMOD	_	_
8	activation	_	NN	_	_	7	PMOD	_	_
9	of	_	IN	_	_	8	NMOD	_	_
10	IkappaB	_	NN	_	_	11	NMOD	_	_
11	kinase	_	NN	_	_	9	PMOD	_	_
12	and	_	CC	_	_	11	COORD	_	_
13	nuclear	_	JJ	_	_	15	NMOD	_	_
14	factor	_	NN	_	_	15	NMOD	_	_
15	kappaB	_	NN	_	_	12	CONJ	_	_
16	in	_	IN	_	_	8	NMOD	_	_
17	response	_	NN	_	_	16	PMOD	_	_
18	to	_	TO	_	_	17	NMOD	_	_
19	B	_	NN	_	_	22	NMOD	_	_
20	cell	_	NN	_	_	22	NMOD	_	_
21	receptor	_	NN	_	_	22	NMOD	_	_
22	engagement	_	NN	_	_	18	PMOD	_	_
23	.	_	.	_	_	5	P	_	_
		
1	Mutations	_	NNS	_	_	13	VMOD	_	_
2	in	_	IN	_	_	1	NMOD	_	_
3	the	_	DT	_	_	4	NMOD	_	_
4	gene	_	NN	_	_	2	PMOD	_	_
5	encoding	_	VBG	_	_	4	APPO	_	_
6	Bruton	_	NN	_	_	9	NMOD	_	_
7	's	_	POS	_	_	9	SUFFIX	_	_
8	tyrosine	_	NN	_	_	9	NMOD	_	_
9	kinase	_	NN	_	_	5	VMOD	_	_
10	(	_	(	_	_	11	P	_	_
11	btk	_	NN	_	_	9	PRN	_	_
12	)	_	)	_	_	11	P	_	_
13	cause	_	VBP	_	_	0	ROOT	_	_
14	the	_	DT	_	_	18	NMOD	_	_
15	B	_	NN	_	_	18	NMOD	_	_
16	cell	_	NN	_	_	18	NMOD	_	_
17	deficiency	_	NN	_	_	18	NMOD	_	_
18	diseases	_	NNS	_	_	13	VMOD	_	_
19	X-linked	_	JJ	_	_	20	NMOD	_	_
20	agammaglobulinemia	_	NN	_	_	18	APPO	_	_
21	(	_	(	_	_	22	P	_	_
22	XLA	_	NN	_	_	20	PRN	_	_
23	)	_	)	_	_	22	P	_	_
24	in	_	IN	_	_	20	NMOD	_	_
25	humans	_	NNS	_	_	24	PMOD	_	_
26	and	_	CC	_	_	25	COORD	_	_
27	X-linked	_	JJ	_	_	28	NMOD	_	_
28	immunodeficiency	_	NN	_	_	26	CONJ	_	_
29	(	_	(	_	_	30	P	_	_
30	xid	_	NN	_	_	28	PRN	_	_
31	)	_	)	_	_	30	P	_	_
32	in	_	IN	_	_	20	NMOD	_	_
33	mice	_	NNS	_	_	32	PMOD	_	_
34	.	_	.	_	_	13	P	_	_
		
1	In	_	FW	_	_	2	AMOD	_	_
2	vivo	_	FW	_	_	6	NMOD	_	_
3	and	_	CC	_	_	2	COORD	_	_
4	in	_	FW	_	_	5	AMOD	_	_
5	vitro	_	FW	_	_	3	CONJ	_	_
6	studies	_	NNS	_	_	7	VMOD	_	_
7	indicate	_	VBP	_	_	0	ROOT	_	_
8	that	_	IN	_	_	7	VMOD	_	_
9	the	_	DT	_	_	11	NMOD	_	_
10	BTK	_	NN	_	_	11	NMOD	_	_
11	protein	_	NN	_	_	12	VMOD	_	_
12	is	_	VBZ	_	_	8	SUB	_	_
13	essential	_	JJ	_	_	12	VMOD	_	_
14	for	_	IN	_	_	13	AMOD	_	_
15	B	_	NN	_	_	17	NMOD	_	_
16	cell	_	NN	_	_	17	NMOD	_	_
17	survival	_	NN	_	_	14	PMOD	_	_
18	,	_	,	_	_	17	P	_	_
19	cell	_	NN	_	_	21	NMOD	_	_
20	cycle	_	NN	_	_	21	NMOD	_	_
21	progression	_	NN	_	_	17	COORD	_	_
22	,	_	,	_	_	21	P	_	_
23	and	_	CC	_	_	21	COORD	_	_
24	proliferation	_	NN	_	_	23	CONJ	_	_
25	in	_	IN	_	_	17	NMOD	_	_
26	response	_	NN	_	_	25	PMOD	_	_
27	to	_	TO	_	_	26	NMOD	_	_
28	B	_	NN	_	_	31	NMOD	_	_
29	cell	_	NN	_	_	31	NMOD	_	_
30	antigen	_	NN	_	_	31	NMOD	_	_
31	receptor	_	NN	_	_	35	NMOD	_	_
32	(	_	(	_	_	33	P	_	_
33	BCR	_	NN	_	_	31	PRN	_	_
34	)	_	)	_	_	33	P	_	_
35	stimulation	_	NN	_	_	27	PMOD	_	_
36	.	_	.	_	_	7	P	_	_
		
1	BCR	_	NN	_	_	2	NMOD	_	_
2	stimulation	_	NN	_	_	3	VMOD	_	_
3	leads	_	VBZ	_	_	0	ROOT	_	_
4	to	_	TO	_	_	3	VMOD	_	_
5	the	_	DT	_	_	6	NMOD	_	_
6	activation	_	NN	_	_	4	PMOD	_	_
7	of	_	IN	_	_	6	NMOD	_	_
8	transcription	_	NN	_	_	15	NMOD	_	_
9	factor	_	NN	_	_	15	NMOD	_	_
10	nuclear	_	JJ	_	_	15	NMOD	_	_
11	factor	_	NN	_	_	15	NMOD	_	_
12	(	_	(	_	_	15	P	_	_
13	NF	_	NN	_	_	15	NMOD	_	_
14	)	_	)	_	_	15	P	_	_
15	-kappaB	_	NN	_	_	7	PMOD	_	_
16	,	_	,	_	_	15	P	_	_
17	which	_	WDT	_	_	20	VMOD	_	_
18	in	_	IN	_	_	20	VMOD	_	_
19	turn	_	NN	_	_	18	PMOD	_	_
20	regulates	_	VBZ	_	_	15	NMOD	_	_
21	genes	_	NNS	_	_	20	VMOD	_	_
22	controlling	_	VBG	_	_	21	APPO	_	_
23	B	_	NN	_	_	25	NMOD	_	_
24	cell	_	NN	_	_	25	NMOD	_	_
25	growth	_	NN	_	_	22	VMOD	_	_
26	.	_	.	_	_	3	P	_	_
		
1	We	_	PRP	_	_	3	VMOD	_	_
2	now	_	RB	_	_	3	VMOD	_	_
3	demonstrate	_	VBP	_	_	0	ROOT	_	_
4	that	_	IN	_	_	3	VMOD	_	_
5	a	_	DT	_	_	7	NMOD	_	_
6	null	_	JJ	_	_	7	NMOD	_	_
7	mutation	_	NN	_	_	16	VMOD	_	_
8	in	_	IN	_	_	7	NMOD	_	_
9	btk	_	NN	_	_	8	PMOD	_	_
10	known	_	VBN	_	_	7	APPO	_	_
11	to	_	TO	_	_	10	VMOD	_	_
12	cause	_	VB	_	_	11	IM	_	_
13	the	_	DT	_	_	15	NMOD	_	_
14	xid	_	JJ	_	_	15	NMOD	_	_
15	phenotype	_	NN	_	_	12	VMOD	_	_
16	prevents	_	VBZ	_	_	4	SUB	_	_
17	BCR-induced	_	JJ	_	_	18	NMOD	_	_
18	activation	_	NN	_	_	16	VMOD	_	_
19	of	_	IN	_	_	18	NMOD	_	_
20	NF-kappaB	_	NN	_	_	19	PMOD	_	_
21	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	defect	_	NN	_	_	3	VMOD	_	_
3	can	_	MD	_	_	0	ROOT	_	_
4	be	_	VB	_	_	3	VC	_	_
5	rescued	_	VBN	_	_	4	VC	_	_
6	by	_	IN	_	_	5	VMOD	_	_
7	reconstitution	_	NN	_	_	6	PMOD	_	_
8	with	_	IN	_	_	7	NMOD	_	_
9	wild-type	_	JJ	_	_	10	NMOD	_	_
10	BTK	_	NN	_	_	8	PMOD	_	_
11	.	_	.	_	_	3	P	_	_
		
1	This	_	DT	_	_	2	NMOD	_	_
2	mutation	_	NN	_	_	4	VMOD	_	_
3	also	_	RB	_	_	4	VMOD	_	_
4	interferes	_	VBZ	_	_	0	ROOT	_	_
5	with	_	IN	_	_	4	VMOD	_	_
6	BCR-directed	_	JJ	_	_	7	NMOD	_	_
7	activation	_	NN	_	_	5	PMOD	_	_
8	of	_	IN	_	_	7	NMOD	_	_
9	IkappaB	_	NN	_	_	10	NMOD	_	_
10	kinase	_	NN	_	_	8	PMOD	_	_
11	(	_	(	_	_	12	P	_	_
12	IKK	_	NN	_	_	10	PRN	_	_
13	)	_	)	_	_	12	P	_	_
14	,	_	,	_	_	10	P	_	_
15	which	_	WDT	_	_	17	VMOD	_	_
16	normally	_	RB	_	_	17	VMOD	_	_
17	targets	_	VBZ	_	_	10	NMOD	_	_
18	the	_	DT	_	_	21	NMOD	_	_
19	NF-kappaB	_	NN	_	_	21	NMOD	_	_
20	inhibitor	_	NN	_	_	21	NMOD	_	_
21	IkappaBalpha	_	NN	_	_	17	VMOD	_	_
22	for	_	IN	_	_	17	VMOD	_	_
23	degradation	_	NN	_	_	22	PMOD	_	_
24	.	_	.	_	_	4	P	_	_
		
1	Taken	_	VBN	_	_	6	VMOD	_	_
2	together	_	RB	_	_	1	VMOD	_	_
3	,	_	,	_	_	6	P	_	_
4	these	_	DT	_	_	5	NMOD	_	_
5	findings	_	NNS	_	_	6	VMOD	_	_
6	indicate	_	VBP	_	_	0	ROOT	_	_
7	that	_	IN	_	_	6	VMOD	_	_
8	BTK	_	NN	_	_	9	VMOD	_	_
9	couples	_	VBZ	_	_	7	SUB	_	_
10	IKK	_	NN	_	_	9	VMOD	_	_
11	and	_	CC	_	_	10	COORD	_	_
12	NF-kappaB	_	NN	_	_	11	CONJ	_	_
13	to	_	TO	_	_	9	VMOD	_	_
14	the	_	DT	_	_	15	NMOD	_	_
15	BCR	_	NN	_	_	13	PMOD	_	_
16	.	_	.	_	_	6	P	_	_
		
1	Interference	_	NN	_	_	6	VMOD	_	_
2	with	_	IN	_	_	1	NMOD	_	_
3	this	_	DT	_	_	5	NMOD	_	_
4	coupling	_	NN	_	_	5	NMOD	_	_
5	mechanism	_	NN	_	_	2	PMOD	_	_
6	may	_	MD	_	_	0	ROOT	_	_
7	contribute	_	VB	_	_	6	VC	_	_
8	to	_	TO	_	_	7	VMOD	_	_
9	the	_	DT	_	_	12	NMOD	_	_
10	B	_	NN	_	_	12	NMOD	_	_
11	cell	_	NN	_	_	12	NMOD	_	_
12	deficiencies	_	NNS	_	_	8	PMOD	_	_
13	observed	_	VBN	_	_	12	APPO	_	_
14	in	_	IN	_	_	13	VMOD	_	_
15	XLA	_	NN	_	_	14	PMOD	_	_
16	and	_	CC	_	_	15	COORD	_	_
17	xid	_	NN	_	_	16	CONJ	_	_
18	.	_	.	_	_	6	P	_	_
		
